Fundraising Fox
/Companies
Sign in

Serna Bio

YC W21

Ontario, US · Founded 2021 · 5 employees · 10 known investors

Find your way into Serna Bio

Sign up to see every warm intro you have to Serna Bio

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the Serna Bio team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Sign up with GoogleAlready have an account? Log in

Serna builds a platform to unlock the transcriptome as a drug target for drug discovery. The company integrates technology and biology to change drug discovery processes.

Also known as Ladder Therapeutics INC · Ladder Therapeutics (LTX)

AI & Machine LearningBiotechDeep TechHealthtechDrug discoveryUnited States of AmericaAmerica / CanadaPartly Remote

Founders & leadership· Y Combinator alumni (W21)

Serna Bio was founded in 2021 by Rabia Khan.

RKRabia Khan
Rabia KhanFounder/CEORabia Khan previously led machine learning efforts at Sensyne Health and worked at BenevolentAI. She now focuses on small-molecule RNA therapeutics.
ALAaron Lazarus
Aaron LazarusChief of StaffFounder at Encepheal Therapeutics
PB
Paul Bradley-LawHead of People Opsformer

Investors · 10

Hummingbird Ventureslisted by Hummingbird VenturesBrussels · $500K – $10M

How we know: Hummingbird Ventures's portfolio page · funding news · the VCSheet dataset · open dataset · 5k.vc investor directory · Y Combinator's founder network · Not right? Tell us

Lifeforce Capitallisted by Lifeforce CapitalChevy Chase · $500K – $5M

How we know: Lifeforce Capital's portfolio page · the VCSheet dataset · Y Combinator's founder network · Not right? Tell us

Y Combinatorlisted by Y CombinatorSan Francisco · $500K

How we know: the Y Combinator directory · funding news · open dataset · 5k.vc investor directory · Not right? Tell us

AME Cloud VenturesreportedPalo Alto · $1M – $10M

How we know: Y Combinator's founder network · Not right? Tell us

Amino CollectivereportedBerlin · $216K – $1.6M

How we know: Y Combinator's founder network · Not right? Tell us

Axial VCreportedSan Francisco · $100K – $5M

How we know: Y Combinator's founder network · Not right? Tell us

Fifty YearsreportedSan Francisco · $250K – $2M

How we know: Y Combinator's founder network · Not right? Tell us

Harvard Management CompanyreportedAllston

How we know: Y Combinator's founder network · Not right? Tell us

Schox Venture CapitalreportedLynnwood

How we know: Y Combinator's founder network · Not right? Tell us

Founder mafia

2 people who came through Serna Bio went on to found or lead other companies.

Aaron LazarusChief of StaffFounded Encepheal TherapeuticsEesha SharmaConsultantFounded Lamar Health

Related companies · 10

Sionna TherapeuticsSionna Therapeutics is a biopharmaceutical company founded in 2019 that develops small-molecule therapies for cystic fibrosis by targeting and stabilizing NBD1, the domain of the CFTR protein where the common ΔF508 mutation occurs. It is advancing a portfolio of NBD1 stabilizers and complementary CFTR modulators intended to be used in combination to normalize CFTR function in CF patients.
Notable LabsNotable Labs operates an automated laboratory that tests combinations of existing drugs against individual patients' blood cancer cells to identify effective treatment options for patients whose cancers have become resistant to standard therapies.
ACXACX develops bioengineered solutions for pest control in agriculture, replacing synthetic chemicals with precision biocides. The company serves crop producers and aims to enhance food security while reducing chemical dependence and promoting biodiversity.
Anto BiosciencesAnto is an AI research lab developing foundation models for microbial communities to enable precision medicine by computationally modeling how the microbiome affects individual drug response. The company serves pharmaceutical and clinical research by combining AI with genomic and microbiome data.
Syrna TherapeuticsSyrna Therapeutics is a biotech company developing small-molecule covalent translation inhibitors that bind and modify structured domains in the mRNA of disease-causing proteins to block their expression. It uses a 3D structure-guided drug discovery platform, with lead programs in immunology and neurodegeneration and a broader pipeline spanning metabolic disease and oncology.
Eris BiotechEris Biotech develops small-molecule drugs designed to block immune suppression mechanisms, allowing the immune system to attack solid tumors; the company is initially focusing on mesothelioma treatments.
SirnaomicsSirnaomics is an RNA therapeutics company developing RNA interference (RNAi) drugs using its proprietary PNP (Peptide Nanoparticle) delivery platform for extra-hepatic delivery and its GalAHead technology for controlling therapeutic duration. Its pipeline spans oncology, regenerative and aesthetic medicine, and cardiovascular and metabolic diseases.
RonatherapeuticsRona Therapeutics develops siRNA-based therapeutics using its GAIA platform to target metabolic and cardiovascular conditions including hypertriglyceridemia, obesity, ASCVD, and MASH. Its pipeline includes APOC3, INHBE, PCSK9-Lp(a), and angiotensinogen-targeting candidates for patients with cardiovascular and metabolic diseases.
Switch TherapeuticsSwitch Therapeutics develops RNA interference (RNAi) therapeutic applications targeting central nervous system diseases, leveraging research from Caltech, Harvard Medical School, and City of Hope.
Silence TherapeuticsSilence Therapeutics is a biotechnology company that discovers and develops short interfering RNA (siRNA) molecules designed to reduce the production of disease-associated proteins through the natural mechanism of RNA interference, with its proprietary mRNAi GOLD platform targeting specific genes in the liver for rare and common diseases.

Companies working in the same space as Serna Bio.

Legal entities · 1

corporate structure
Ladder Therapeutics INC

Frequently asked questions

What does Serna Bio do?
Serna builds a platform to unlock the transcriptome as a drug target for drug discovery. The company integrates technology and biology to change drug discovery processes.
Who founded Serna Bio?
Serna Bio was founded by Rabia Khan in 2021.
Who are Serna Bio's investors?
Serna Bio's investors include Backed, Hummingbird Ventures, Lifeforce Capital, Y Combinator, AME Cloud Ventures, Amino Collective, Axial VC, Fifty Years and 2 more.
Where is Serna Bio headquartered?
Serna Bio is headquartered in Ontario, US.